Autopsy report · NCT06017427

Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite Appropriate Medical and Surgical Treatment.

“Number of inclusions sufficient for answering the main objective”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 month before it stopped.
• 32 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

IHU Strasbourg

Sponsor type

University, hospital or other

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

Questionnaires

Participants

32

Sites

1

Countries

France

Trials that died the same way

• Pronostic Value of Endothelial Dysfunction in Heart Failure
  “Not enough inclusions” (68% match in meaning)
• Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
  “Too few inclusions” (68% match in meaning)
• Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care.
  “insufficient inclusions” (66% match in meaning)
• Assessment of Inspiratory Muscles Strength and Endurance Evolution on Difficult to Wean Patients in Intensive Care Unit
  “target number of inclusion no reached” (66% match in meaning)
• Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
  “inclusion number not sufficient” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.